Has Sorafenib been officially included in medical insurance coverage?

Sorafenib/Nexavar (Sorafenib) is a multi-target tyrosine kinase inhibitor with significant anti-tumor activity. Its main indications include advanced renal cell carcinoma (RCC), unresectable liver cancer (HCC), and differentiated thyroid cancer with recurrence or distant metastasis. Sorafenib significantly inhibits tumor cell proliferation and reduces neovascularization by blocking the Raf/MEK/ERK signaling pathway and inhibiting vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR), thereby delaying tumor progression.

In advanced kidney cancer, sorafenib can slow the progression of the disease and is one of the standard treatments for patients who cannot undergo surgery. Among patients with hepatocellular carcinoma, sorafenib is especially suitable for late-stage patients with acceptable liver function and relatively stable disease, and can prolong progression-free survival. For patients with differentiated thyroid cancer, sorafenib can be used for cases of recurrence or distant metastasis after surgery and radiotherapy, providing a new clinical treatment option.

Domestically, sorafenib has been officially included in the medical insurance reimbursement catalog, which means that eligible patients can enjoy a certain proportion of medical insurance reimbursement when treated with sorafenib, reducing the financial burden. This policy is particularly important for patients with advanced cancer, as long-term use of sorafenib may result in higher treatment costs. The inclusion in medical insurance also reflects the country’s recognition of the efficacy and safety of sorafenib in clinical practice. Before using sorafenib, patients should consult their doctors to evaluate their liver and kidney function, previous treatment history and physical condition to ensure the safety of the drug. Liver function, kidney function and blood indicators should be regularly monitored during the treatment process to adjust the dosage and deal with possible adverse reactions in a timely manner.

Reference materials:https://www.nexavar.com/